Literature DB >> 9688323

Peroxynitrite formation within the central nervous system in active multiple sclerosis.

A H Cross1, P T Manning, R M Keeling, R E Schmidt, T P Misko.   

Abstract

Peroxynitrite, generated by the reaction of nitric oxide (NO) with superoxide at sites of inflammation, is a strong oxidant capable of damaging tissues and cells. Detection of nitrotyrosine (NT) at inflammatory sites serves as a biochemical marker for peroxynitrite-mediated damage. In this study, NT was detected immunohistochemically within autopsied CNS tissues from six of nine multiple sclerosis (MS) patients, and in most of the MS sections displaying inflammation. Nitrite and nitrate, the stable oxidation products of NO and peroxynitrite, respectively, were measured in cerebrospinal fluid samples obtained from MS patients and controls. Levels of nitrate were elevated significantly during clinical relapses of MS. These data suggest that peroxynitrite formation is a major consequence of NO produced in MS-affected CNS and implicate a role for this powerful oxidant in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688323     DOI: 10.1016/s0165-5728(98)00078-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  49 in total

1.  Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts.

Authors:  M T Frost; B Halliwell; K P Moore
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Identification of nitrotyrosine containing peptides using combined fractional diagonal chromatography (COFRADIC) and off-line nano-LC-MALDI.

Authors:  Trine R Larsen; Nicolai Bache; Jan Bert Gramsbergen; Peter Roepstorff
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-08       Impact factor: 3.109

Review 3.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

4.  Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  Anne I Boullerne; Jose J Rodriguez; Tarik Touil; Bruno Brochet; Stephan Schmidt; Nora D Abrous; Michel Le Moal; Jeffrey R Pua; Mark A Jensen; Willy Mayo; Barry G W Arnason; Klaus G Petry
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

5.  HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide.

Authors:  Atrayee Banerjee; Xinsheng Zhang; Kalyan Reddy Manda; William A Banks; Nuran Ercal
Journal:  Free Radic Biol Med       Date:  2010-02-24       Impact factor: 7.376

Review 6.  Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Authors:  Hans Lassmann
Journal:  J Neural Transm (Vienna)       Date:  2011-03-05       Impact factor: 3.575

Review 7.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 8.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

9.  Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.

Authors:  Annette Liessem-Schmitz; Nico Teske; Miriam Scheld; Stella Nyamoya; Adib Zendedel; Cordian Beyer; Tim Clarner; Athanassios Fragoulis
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

10.  Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine.

Authors:  V Calabrese; G Scapagnini; A Ravagna; R Bella; D A Butterfield; M Calvani; G Pennisi; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.